Matarin Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Matarin Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-663,050	Closed	-$3.25M	–	269
2019 Q3	$3.25M	Sell	663,050 -38,395	-5%	-$215K	0.25%	147
2019 Q2	$4.27M	Buy	701,445 +6,537	+0.9%	+$34.7K	0.31%	122
2019 Q1	$4.04M	Sell	694,908 -1,553	-0.2%	-$16K	0.29%	126
2018 Q4	$9.37M	Sell	696,461 -926	-0.1%	-$15.6K	0.76%	49
2018 Q3	$13.5M	Buy	697,387 +68,601	+11%	+$1.46M	0.87%	31
2018 Q2	$16.1M	Sell	628,786 -5,965	-0.9%	-$139K	1.16%	10
2018 Q1	$12.8M	Buy	634,751 +53,622	+9%	+$1.25M	0.96%	22
2017 Q4	$11.7M	Buy	581,129 +57,783	+11%	+$1.14M	0.91%	27
2017 Q3	$10.8M	Buy	+523,346	New	+$8.85M	0.92%	23
2016 Q4	–	Sell	-31,702	Closed	-$888K	–	261
2016 Q3	$888K	Buy	+31,702	New	+$1.06M	0.1%	184

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Matarin Capital Management's DPLO Position: Q4 2019 in Review

Matarin Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 663,050 shares — an estimated $3.25M sold.

Matarin Capital Management first reported a position in DPLO in Q3 2016 and held it in 10 quarters. The position peaked at $16.1M in Q2 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

Matarin Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
Matarin Capital Management sold 663,050 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $3.25M.
Matarin Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 10 quarters.
Matarin Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $16.1M in Q2 2018.
138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Matarin Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.